Citi Downgrades Raptor Pharmaceuticals (RPTP) to Neutral
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Citi earlier downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Buy to Neutral.
Shares of Raptor Pharmaceuticals closed at $6.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades VF Corp. (VFC) to Neutral
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
- Deutsche Bank Downgrades Brown & Brown (BRO) to Hold
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!